|
TW224053B
(US07384924-20080610-C00031.png)
*
|
1991-09-13 |
1994-05-21 |
Paul B Chretien |
|
|
SG64892A1
(en)
*
|
1992-02-06 |
1999-05-25 |
Sciclone Pharmaceuticals |
Method for treating hepatitis b carriers with minimal disease
|
|
WO1994001125A1
(en)
*
|
1992-07-13 |
1994-01-20 |
Sherman Kenneth E |
Composition and method of treating hepatitis b
|
|
AU751199B2
(en)
*
|
1992-07-13 |
2002-08-08 |
Government Of The United States Of America As Represented By The Secretary Of The Army |
Composition and method of treating hepatitis B
|
|
CN1072961C
(zh)
*
|
1993-03-05 |
2001-10-17 |
施塞克龙药品公司 |
治疗对干扰素治疗无反应者的丙型肝炎的方法
|
|
US6200952B1
(en)
|
1993-06-02 |
2001-03-13 |
Sciclone Pharmaceuticals, Inc. |
Combination therapy method for treating chronic hepatitis B
|
|
TW249754B
(US07384924-20080610-C00031.png)
*
|
1993-10-26 |
1995-06-21 |
Alpha I Biomedicals Inc |
|
|
MXPA94003453A
(es)
*
|
1993-11-05 |
2004-08-16 |
Alpha 1 Biomedicals Inc |
Metodo y composicion para el tratamiento de pacientes con hepatitis b que tienen descompensacion hepatica.
|
|
JP3837769B2
(ja)
*
|
1995-06-12 |
2006-10-25 |
大塚製薬株式会社 |
抗ウイルス剤
|
|
GEP20012489B
(en)
*
|
1996-02-28 |
2001-07-25 |
Ifi Inst Farmacoterapico Italiano S P A |
Use of Natural Human α-Interferon
|
|
MY164523A
(en)
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
|
CN1315862C
(zh)
|
2000-05-26 |
2007-05-16 |
艾登尼科斯（开曼）有限公司 |
处理黄病毒和瘟病毒的方法和组合物
|
|
US7208167B2
(en)
*
|
2000-08-07 |
2007-04-24 |
Sciclone Pharmaceuticals, Inc. |
Treatment of hepatitis C with thymosin and peptide combination therapy
|
|
MXPA03001145A
(es)
*
|
2000-08-07 |
2004-08-02 |
Sciclone Pharmaceuticals Inc |
Composicion farmaceutica para el tratamiento de la hepatitis c con timocina, interferon y ribavirin.
|
|
US6878364B2
(en)
*
|
2000-12-01 |
2005-04-12 |
Cornell Research Foundation, Inc. |
Animal model for flaviviridae infection
|
|
US7138376B2
(en)
*
|
2001-09-28 |
2006-11-21 |
Idenix Pharmaceuticals, Inc. |
Methods and compositions for treating hepatitis C virus using 4'-modified nucleosides
|
|
HUP0600449A2
(en)
*
|
2001-10-05 |
2006-09-28 |
Intermune |
Methods of treating liver fibrosis and hepatitis c virus infection
|
|
UA81613C2
(ru)
*
|
2001-10-26 |
2008-01-25 |
Род Айленд Хоспитл |
Стимуляция тимозином генетической иммунизации
|
|
UA80957C2
(en)
*
|
2001-11-01 |
2007-11-26 |
Sciclone Pharmaceuticals Inc |
Method of administering a thymosin alpha 1 peptide
|
|
JP2005522443A
(ja)
*
|
2002-02-14 |
2005-07-28 |
フアーマセツト・リミテツド |
改変フッ素化ヌクレオシド類似体
|
|
CN103319554A
(zh)
|
2002-06-28 |
2013-09-25 |
埃迪尼克斯医药公司 |
用于治疗黄病毒感染的修饰的2’和3’-核苷前药
|
|
NZ537662A
(en)
|
2002-06-28 |
2007-10-26 |
Idenix Cayman Ltd |
2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
|
|
US7608600B2
(en)
|
2002-06-28 |
2009-10-27 |
Idenix Pharmaceuticals, Inc. |
Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
|
|
US7456155B2
(en)
|
2002-06-28 |
2008-11-25 |
Idenix Pharmaceuticals, Inc. |
2′-C-methyl-3′-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
|
|
EP1576138B1
(en)
|
2002-11-15 |
2017-02-01 |
Idenix Pharmaceuticals LLC. |
2'-methyl nucleosides in combination with interferon and flaviviridae mutation
|
|
KR20050109918A
(ko)
|
2002-12-12 |
2005-11-22 |
이데닉스 (케이만) 리미티드 |
2'-분지형 뉴클레오시드의 제조 방법
|
|
GB0301879D0
(en)
*
|
2003-01-27 |
2003-02-26 |
Regent Res Llp |
HCV combination therapy
|
|
JP4149296B2
(ja)
*
|
2003-03-26 |
2008-09-10 |
株式会社ルネサステクノロジ |
半導体記憶装置
|
|
ATE467422T1
(de)
*
|
2003-03-28 |
2010-05-15 |
Sciclone Pharmaceuticals Inc |
Behandlung von aspergillus-infektionen mit thymosin alpha 1
|
|
CN100342907C
(zh)
*
|
2003-03-28 |
2007-10-17 |
希克龙制药公司 |
胸腺素α1在制备用于治疗或预防哺乳动物中曲霉菌感染的药物组合物中的应用
|
|
US20100311656A1
(en)
*
|
2003-04-23 |
2010-12-09 |
Sciclone Pharmaceuticals, Inc. |
Treatment or prevention of respiratory viral infections with alpha thymosin peptides
|
|
ES2726998T3
(es)
|
2003-05-30 |
2019-10-11 |
Gilead Pharmasset Llc |
Análogos de nucleósidos fluorados modificados
|
|
RU2006105640A
(ru)
*
|
2003-07-25 |
2007-09-10 |
Айденикс (Кайман) Лимитед (Ky) |
Аналоги пуриновых нуклеозидов для лечения flaviviridae, включая гепатит с
|
|
WO2005021007A1
(fr)
*
|
2003-08-28 |
2005-03-10 |
Obschestvo S Ogranichennoi Otvetstvennostju 'berezovy Mir' |
Prevention et traitement de l'hepatite virale b
|
|
WO2005107742A1
(en)
|
2004-05-05 |
2005-11-17 |
Yale University |
Novel antiviral helioxanthin analogs
|
|
CN101023094B
(zh)
|
2004-07-21 |
2011-05-18 |
法莫赛特股份有限公司 |
烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
|
|
NZ554442A
(en)
|
2004-09-14 |
2011-05-27 |
Pharmasset Inc |
Preparation of 2'fluoro-2'-alkyl-substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives
|
|
JP4516863B2
(ja)
*
|
2005-03-11 |
2010-08-04 |
株式会社ケンウッド |
音声合成装置、音声合成方法及びプログラム
|
|
EP1976382B1
(en)
|
2005-12-23 |
2013-04-24 |
IDENIX Pharmaceuticals, Inc. |
Process for preparing a synthetic intermediate for preparation of branched nucleosides
|
|
EP1832295A1
(en)
*
|
2006-03-10 |
2007-09-12 |
Tecnogen S.P.A. |
Use of PTX3 for the treatment of viral diseases
|
|
EP2012816B1
(en)
*
|
2006-05-02 |
2012-06-27 |
SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. |
Use of thymosin 1, alone or in combination with ptx3 or ganciclovir, for the treatment of cytomegalovirus infection
|
|
ES2288118B1
(es)
*
|
2006-05-10 |
2008-11-01 |
Bcn Peptides, S.A. |
Procedimiento para sintetizar timosinas.
|
|
US7964580B2
(en)
|
2007-03-30 |
2011-06-21 |
Pharmasset, Inc. |
Nucleoside phosphoramidate prodrugs
|
|
TW200946541A
(en)
*
|
2008-03-27 |
2009-11-16 |
Idenix Pharmaceuticals Inc |
Solid forms of an anti-HIV phosphoindole compound
|
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
|
US20110195048A1
(en)
*
|
2008-10-08 |
2011-08-11 |
Podack Eckhard R |
Regulation of lymphocytes and uses therefor
|
|
CN102325783A
(zh)
|
2008-12-23 |
2012-01-18 |
法莫赛特股份有限公司 |
嘌呤核苷的合成
|
|
CA2748034A1
(en)
|
2008-12-23 |
2010-07-01 |
Pharmasset, Inc. |
Purified 2'-deoxy'2'-fluoro-2'-c-methyl-nucleoside-phosphoramidate prodrugs for the treatment of viral infections
|
|
PA8855601A1
(es)
|
2008-12-23 |
2010-07-27 |
|
Forformidatos de nucleósidos
|
|
WO2010129947A2
(en)
|
2009-05-08 |
2010-11-11 |
Sciclone Pharmaceuticals, Inc. |
Alpha thymosin peptides as vaccine enhancers
|
|
US8618076B2
(en)
|
2009-05-20 |
2013-12-31 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidates
|
|
TWI576352B
(zh)
*
|
2009-05-20 |
2017-04-01 |
基利法瑪席特有限責任公司 |
核苷磷醯胺
|
|
SG184323A1
(en)
|
2010-03-31 |
2012-11-29 |
Gilead Pharmasett Llc |
Stereoselective synthesis of phosphorus containing actives
|
|
US8563530B2
(en)
|
2010-03-31 |
2013-10-22 |
Gilead Pharmassel LLC |
Purine nucleoside phosphoramidate
|
|
CA2818853A1
(en)
|
2010-11-30 |
2012-06-07 |
Gilead Pharmasset Llc |
2'-spirocyclo-nucleosides for use in therapy of hcv or dengue virus
|
|
US8889159B2
(en)
|
2011-11-29 |
2014-11-18 |
Gilead Pharmasset Llc |
Compositions and methods for treating hepatitis C virus
|
|
US8809354B2
(en)
|
2011-12-31 |
2014-08-19 |
Sheikh Riazuddin |
3-amino-2-(4-nitrophenyl)-4-(3H)-quinazolinone or derivatives thereof for treating or preventing antiviral infections
|
|
CN103800293B
(zh)
*
|
2012-11-09 |
2015-10-21 |
长春海悦药业有限公司 |
一种含有胸腺法新的药物组合物及其制剂
|
|
PL3038601T3
(pl)
|
2013-08-27 |
2020-08-24 |
Gilead Pharmasset Llc |
Formulacja złożona dwóch związków przeciwwirusowych
|
